View Article

  • Recent Advances In Eco-Friendly Synthetic Approaches For Heterocyclic Compounds: Targeting Type-2 Diabetes And Beyond

  • Student, Long Island University. 1 University plaza, Brooklyn, New York 11201.

Abstract

Heterocyclic compounds are critical in the development of therapeutic agents, particularly in managing Type-2 Diabetes Mellitus (T2DM). However, traditional synthetic methods for these compounds often involve the use of toxic reagents, non-renewable resources, and harsh conditions, leading to significant environmental concerns. This review explores recent advancements in eco-friendly synthetic approaches for heterocyclic compounds, focusing on green chemistry principles, such as the use of renewable feedstocks, safer solvents, and mild reaction conditions. These methods not only reduce the environmental footprint of chemical synthesis but also enhance the efficiency and safety of the resulting pharmaceuticals. Additionally, the role of innovative pharmaceutical formulations and novel drug delivery systems (NDDS) in improving the therapeutic efficacy of these compounds is discussed, with particular emphasis on their application in the treatment of T2DM.

Keywords

Heterocyclic compounds, Type-2 Diabetes Mellitus, Green chemistry, Eco-friendly synthesis, Renewable feedstocks, Pharmaceutical formulations, Novel drug delivery systems

Introduction

Heterocyclic compounds are a cornerstone of medicinal chemistry, offering a diverse range of biological activities that make them indispensable in the development of pharmaceuticals. These compounds, characterized by rings containing at least one atom other than carbon, have been particularly valuable in the treatment of Type-2 Diabetes Mellitus (T2DM), a chronic condition affecting millions worldwide. The traditional synthesis of these heterocycles often involves the use of hazardous reagents, harsh conditions, and non-renewable resources, leading to significant environmental concerns. As the demand for more sustainable and eco-friendly processes grows, the field of green chemistry has emerged as a crucial area of research. This review aims to provide a comprehensive overview of recent advances in the eco-friendly synthesis of heterocyclic compounds, with a particular focus on their application as ?-glucosidase inhibitors for managing T2DM. We will explore the principles of green chemistry that guide these advancements, discuss various synthetic methodologies such as microwave-assisted synthesis, solvent-free reactions, and biocatalysis, and examine their practical applications in the pharmaceutical industry. [1-38]

PRINCIPLES OF GREEN CHEMISTRY

Green chemistry is an innovative approach that aims to design chemical products and processes that reduce or eliminate the use and generation of hazardous substances. This approach is guided by twelve principles, which serve as a framework for developing more sustainable chemical practices. These principles include the use of renewable feedstocks, the design of safer chemicals and solvents, the increase of energy efficiency, and the reduction of waste generation. In the context of heterocyclic synthesis, these principles are particularly important, as they address the environmental challenges posed by traditional synthetic methods.

Use of Renewable Feedstocks:

Renewable feedstocks are materials derived from natural resources, such as plants, which can be replenished over short periods. In heterocyclic synthesis, the use of renewable feedstocks has gained traction as a means of reducing the reliance on fossil fuels and minimizing the carbon footprint of chemical processes. For example, carbohydrate-derived building blocks have been used in the synthesis of various heterocyclic compounds, including pyran derivatives, which have shown potential as ?-glucosidase inhibitors.

Safer Solvents and Reaction Conditions

The choice of solvent is a critical factor in the environmental impact of a chemical process. Traditional solvents, such as dichloromethane and benzene, are often toxic and non-biodegradable, posing risks to both human health and the environment. Green solvents, such as water, ethanol, and ionic liquids, offer a safer and more sustainable alternative. These solvents are not only less toxic but also often more efficient in promoting the desired chemical reactions. For instance, water, which is abundant and non-toxic, has been successfully used as a solvent in the synthesis of various heterocyclic compounds. Additionally, the use of solvent-free conditions, where reactions occur without any added solvents, further enhances the environmental friendliness of the process. Reaction conditions, such as temperature and pressure, also play a significant role in the sustainability of chemical processes. Green chemistry advocates for the use of milder reaction conditions to reduce energy consumption and prevent the degradation of sensitive molecules. Techniques such as microwave-assisted synthesis, which can rapidly heat reactants and drive reactions to completion under milder conditions, have been increasingly adopted in the synthesis of heterocycles. [39-75]

ECO-FRIENDLY SYNTHETIC METHODS FOR HETEROCYCLIC COMPOUNDS PATHOPHYSIOLOGY

Microwave-Assisted Synthesis:

Microwave-assisted synthesis has revolutionized the field of organic chemistry by offering a rapid and energy-efficient means of driving chemical reactions. This technique utilizes microwave radiation to heat reactants directly, leading to faster reaction rates and higher yields compared to conventional heating methods. In the synthesis of heterocyclic compounds, microwave-assisted methods have been shown to not only reduce reaction times but also enhance product purity and selectivity. For example, the synthesis of quinoline and pyrimidine derivatives under microwave irradiation has been achieved with remarkable efficiency, making this technique an attractive option for large-scale production.

Solvent-Free Reactions:

Solvent-free reactions represent an ideal approach to minimizing waste and reducing the environmental impact of chemical processes. By eliminating the need for solvents, these reactions reduce waste, lower costs, and eliminate the environmental and health risks associated with solvent disposal. In the context of heterocyclic synthesis, solvent-free methods have been employed to produce a variety of biologically active compounds. For instance, the synthesis of 1,3,4-oxadiazoles has been successfully carried out using a solvent-free approach, where acyl hydrazides and carboxylic acids react in the presence of a catalytic amount of acid, yielding high-purity products. This method not only aligns with the principles of green chemistry but also offers significant practical benefits.

Biocatalysis in Heterocyclic Synthesis:

Biocatalysis, the use of natural catalysts such as enzymes to accelerate chemical reactions, is another promising green chemistry approach. Enzymes are highly selective and can operate under mild conditions, making them ideal for the synthesis of complex molecules with minimal environmental impact. In heterocyclic synthesis, biocatalysis has been employed to achieve high enantioselectivity, particularly in the formation of chiral heterocycles. For example, lipase-catalyzed esterification has been used to synthesize chiral lactones, which are valuable intermediates in the production of biologically active heterocycles. The use of biocatalysis not only enhances the sustainability of the synthetic process but also provides access to compounds with high stereochemical purity. [76-85]

COMPARATIVE OVERVIEW OF ECO-FRIENDLY SYNTHESIS METHODS

A comparative analysis of different eco-friendly synthesis methods highlights the advantages and challenges associated with each approach. The following table provides an overview of these methods, focusing on their application to heterocyclic compound synthesis, environmental impact, and scalability.


Table 1 A comparison of different eco-friendly synthesis methods

       
            pp.png
       

    

 

APPLICATIONS IN TYPE-2 DIABETES MELLITUS TREATMENT

The application of eco-friendly synthesis methods in the development of therapeutic agents for Type-2 Diabetes Mellitus (T2DM) has garnered significant attention. Heterocyclic compounds, particularly those functioning as ?-glucosidase inhibitors, have shown great promise in managing T2DM by controlling postprandial blood glucose levels. This section explores the role of these compounds in T2DM treatment, with a focus on the advantages of using green synthetic approaches.

?-Glucosidase Inhibitors: Mechanism of Action:

?-Glucosidase inhibitors are a class of compounds that inhibit the enzymatic breakdown of carbohydrates into glucose in the small intestine. This inhibition slows the absorption of carbohydrates, thereby reducing the postprandial rise in blood glucose levels. This mechanism is particularly beneficial for individuals with Type-2 Diabetes Mellitus, as it helps maintain better control over blood sugar levels. Several heterocyclic compounds have been identified as potent ?-glucosidase inhibitors, and their synthesis via eco-friendly methods is a promising area of research. [86-90]

ECO-FRIENDLY FORMULATIONS AND NOVEL DRUG DELIVERY SYSTEMS (NDDS)

In addition to the eco-friendly synthesis of heterocyclic compounds, the development of novel formulations and drug delivery systems (NDDS) plays a critical role in enhancing the therapeutic efficacy and safety of pharmaceutical agents. Green chemistry principles can be extended to the design of formulations and NDDS, ensuring that these delivery systems are not only effective but also environmentally sustainable.

Green Formulations:

Green formulations involve the use of safer excipients, solvents, and processes that align with the principles of green chemistry. For example, the use of biodegradable polymers derived from renewable resources in the formulation of drug delivery systems can reduce the environmental impact associated with synthetic polymers. Additionally, solvent-free or water-based formulations can minimize the use of harmful organic solvents, resulting in safer and more sustainable pharmaceutical products. In the context of heterocyclic compounds, these green formulations can improve the stability, bioavailability, and patient compliance of the therapeutic agents.

Novel Drug Delivery Systems (NDDS):

Novel Drug Delivery Systems (NDDS) have emerged as a transformative approach in the field of pharmaceuticals, providing innovative solutions to some of the most challenging aspects of drug administration. Traditional drug delivery methods often face limitations such as poor bioavailability, rapid degradation of the drug in the body, and a lack of targeted delivery, which can lead to suboptimal therapeutic outcomes and increased side effects. NDDS address these issues by enabling controlled release, targeted delivery, and enhanced bioavailability, thus improving the overall efficacy and safety of therapeutics.

Controlled Release and Targeted Delivery

One of the key advantages of NDDS is their ability to offer controlled release of drugs. Controlled release refers to the delivery of a drug at a predetermined rate, for a specified period, and often to a specific target site. This approach ensures that the drug maintains its therapeutic concentration in the bloodstream for an extended duration, reducing the frequency of dosing and enhancing patient compliance. Additionally, controlled release minimizes the peaks and troughs associated with conventional drug administration, leading to more stable therapeutic effects and reduced side effects. Targeted delivery, another significant benefit of NDDS, allows drugs to be delivered specifically to the site of action, such as a particular tissue, organ, or type of cell. This precision in delivery is particularly advantageous in the treatment of diseases like cancer, where traditional chemotherapy can affect both healthy and cancerous cells, leading to severe side effects. By directing the drug specifically to cancer cells, NDDS can reduce the impact on healthy tissues, thereby improving the safety and effectiveness of the treatment.

Integration of Green Chemistry in NDDS

The integration of green chemistry principles into the development of NDDS represents a significant advancement in the pursuit of sustainability in pharmaceutical development. Green chemistry focuses on designing products and processes that minimize the use and generation of hazardous substances, thereby reducing environmental impact and improving safety for both patients and the environment. One of the most promising examples of green NDDS is the use of niosomes. Niosomes are non-ionic surfactant-based vesicles that have shown great potential as drug carriers in various therapeutic applications, including cancer treatment. These vesicles are biodegradable and biocompatible, meaning they break down into harmless by-products in the body and do not provoke an immune response. Niosomes are also versatile in their ability to encapsulate both hydrophilic (water-soluble) and lipophilic (fat-soluble) drugs, making them suitable for a wide range of pharmaceutical formulations. The design and development of niosomes as green NDDS offer several advantages over traditional drug delivery systems. Firstly, the biodegradable nature of niosomes ensures that they do not accumulate in the body or the environment, reducing the risk of long-term toxicity. Secondly, their biocompatibility minimizes the potential for adverse immune reactions, which is particularly important in chronic treatments or therapies requiring repeated administration. Finally, the ability of niosomes to encapsulate various types of drugs allows for the development of multifunctional delivery systems that can target multiple pathways in a disease, potentially improving therapeutic outcomes.

Lipid-Based Nanoparticles and Polymeric Micelles

In addition to niosomes, other eco-friendly materials such as lipid-based nanoparticles and polymeric micelles are increasingly being used in NDDS to enhance the delivery of therapeutic agents, particularly in the treatment of diseases like Type-2 Diabetes Mellitus (T2DM). Lipid-based nanoparticles are composed of natural or synthetic lipids that form a spherical structure capable of encapsulating drugs. These nanoparticles offer several benefits, including enhanced bioavailability of poorly soluble drugs, protection of drugs from degradation in the gastrointestinal tract, and the ability to target specific tissues. In the context of T2DM, lipid-based nanoparticles can be engineered to deliver drugs directly to pancreatic cells or other target tissues, thereby improving glucose regulation and reducing systemic side effects. Furthermore, lipid-based nanoparticles are typically made from biodegradable materials, which aligns with the principles of green chemistry by reducing environmental impact. Polymeric micelles are another class of NDDS that have garnered attention for their potential in drug delivery. These micelles are formed by the self-assembly of amphiphilic block copolymers in an aqueous environment, resulting in a core-shell structure. The hydrophobic core can encapsulate lipophilic drugs, while the hydrophilic shell stabilizes the micelle in the bloodstream. Polymeric micelles are particularly useful in delivering hydrophobic drugs, which often have poor bioavailability and are prone to rapid clearance from the body. By encapsulating these drugs, polymeric micelles improve their solubility, stability, and circulation time, leading to better therapeutic outcomes.

In the treatment of T2DM, polymeric micelles can be designed to release drugs in a controlled manner, ensuring a steady concentration of the drug in the bloodstream and minimizing the risk of hypoglycemia. Additionally, polymeric micelles can be functionalized with targeting ligands that direct the drug to specific receptors on pancreatic cells, enhancing the precision and efficacy of the treatment.

Balancing Therapeutic Efficacy and Environmental Sustainability

The incorporation of green chemistry principles into NDDS not only improves the therapeutic efficacy of drugs but also addresses the growing need for environmentally sustainable pharmaceutical practices. By utilizing biodegradable and biocompatible materials such as niosomes, lipid-based nanoparticles, and polymeric micelles, pharmaceutical development can reduce the environmental burden associated with traditional drug delivery systems. Moreover, the design of NDDS that offer controlled release and targeted delivery reduces the overall dosage required to achieve therapeutic effects. This reduction in dosage not only minimizes potential side effects but also decreases the amount of active pharmaceutical ingredients released into the environment, either through patient excretion or manufacturing waste. In summary, NDDS represent a significant advancement in drug delivery technology, offering the potential for more effective and safer therapies. The integration of green chemistry principles into the development of these systems further enhances their sustainability, making them a crucial component of future pharmaceutical development. By balancing therapeutic efficacy with environmental responsibility, NDDS pave the way for more sustainable and patient-friendly treatments. [91-94]

FUTURE PERSPECTIVES IN GREEN SYNTHESIS

The future of green synthesis in the development of heterocyclic compounds is promising. Continued research into the optimization of existing methods and the discovery of new eco-friendly technologies will further reduce the environmental impact of chemical synthesis. The integration of renewable feedstocks, safer solvents, and energy-efficient techniques will play a critical role in making the production of these compounds more sustainable. As regulatory pressures increase and the demand for environmentally friendly pharmaceuticals grows, the adoption of green chemistry practices in industrial applications is expected to expand. Further exploration of biocatalysis and the application of emerging technologies, such as flow chemistry and photoredox catalysis, could lead to even more efficient and sustainable processes. Ultimately, the ongoing development of green synthetic approaches will contribute to the creation of safer, more effective therapeutic agents for the treatment of Type-2 Diabetes Mellitus and other diseases.

CONCLUSION

The shift towards eco-friendly synthetic approaches in the field of heterocyclic chemistry represents a significant advancement in sustainable drug development. These methods not only align with the principles of green chemistry but also offer considerable benefits in terms of efficiency, safety, and environmental impact. The reviewed eco-friendly methods, including microwave-assisted synthesis, solvent-free reactions, and biocatalysis, demonstrate that it is possible to achieve high yields and product purity while minimizing the environmental footprint of chemical synthesis. As research in this area continues to evolve, these green synthesis methods are likely to play an increasingly important role in the future of pharmaceutical development, particularly in the treatment of Type-2 Diabetes Mellitus.

CONFLICT OF INTEREST

The author declares that there are no conflicts of interest regarding the publication of this article.

REFERENCES

  1. Bailey CJ, Day C, Campbell IW, Schindler C. Glycaemic control and cardiovascular outcome trials in type 2 diabetes. Vol. 12, British Journal of Diabetes and Vascular Disease. 2012.
  2. Hinnen D, Kruger DF. Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials. Vol. 12, Diabetes, Metabolic Syndrome and Obesity. 2019.
  3. McEwan P, Chubb B, Bennett H. Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials. Value in Health. 2017;20(9).
  4. Cypryk K, Ma?ecki P. A review of cardiovascular outcome trials in type 2 diabetes. Endokrynologia Polska. 2018;69(4).
  5. Kapoor K, George P, Miller M. Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus. Vol. 135, Cardiology (Switzerland). 2016.
  6. Davies MJ, Drexel H, Jornayvaz FR, Pataky Z, Seferovi? PM, Wanner C. Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes. Vol. 21, Cardiovascular Diabetology. 2022.
  7. Bailey CJ, Marx N. Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials. Vol. 21, Diabetes, Obesity and Metabolism. 2019.
  8. Kruger DF. Cardiovascular outcome trials in type 2 diabetes: A nurse practitioner perspective. Journal of the American Association of Nurse Practitioners. 2018;30(1).
  9. Giugliano D, de Nicola L, Maiorino MI, Bellastella G, Esposito K. Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials. Vol. 21, Diabetes, Obesity and Metabolism. 2019.
  10. Schnell O, Rydén L, Standl E, Ceriello A. Current perspectives on cardiovascular outcome trials in diabetes. Vol. 15, Cardiovascular Diabetology. 2016.
  11. Coch RW, Green JB. Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight. Vol. 26, Nutrition, Metabolism and Cardiovascular Diseases. 2016.
  12. Gutiérrez RMP, Gómez JT, Urby RB, Soto JGC, Parra HR. Evaluation of Diabetes Effects of Selenium Nanoparticles Synthesized from a Mixture of Luteolin and Diosmin on Streptozotocin-Induced Type 2 Diabetes in Mice. Molecules. 2022;27(17).
  13. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. Journal of Nutrition. 2006;136(10).
  14. Patel P, Shah D, Bambharoliya T, Patel V, Patel M, Patel D, et al. A Review on the Development of Novel Heterocycles as ?-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus. Medicinal Chemistry. 2024;20(5):503–36.
  15. Kuril AK, Vashi A, Subbappa PK. A comprehensive guide for secondary structure and tertiary structure determination in peptides and proteins by circular dichroism spectrometer. Journal of Peptide Science. 2024;e3648.
  16. Wahab M, Janaswamy S. A review on biogenic silver nanoparticles as efficient and effective antidiabetic agents. Vol. 3, Functional Food Science. 2023.
  17. BORRA R. Formulation Development and Evaluation of Buccal Mucoadhesive Drug Delivery System for Anti Asthmatic Drugs.
  18. Ding M, Liu W, Gref R. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications. Vol. 190, Advanced Drug Delivery Reviews. 2022.
  19. Kuril AK. Navigating Mass Spectrometry: A Comprehensive Guide to Basic Concepts and Techniques.
  20. Abdelghany TM, Al-Rajhi AMH, al Abboud MA, Alawlaqi MM, Ganash Magdah A, Helmy EAM, et al. Recent Advances in Green Synthesis of Silver Nanoparticles and Their Applications: About Future Directions. A Review. Vol. 8, BioNanoScience. 2018.
  21. Virani A, Puri V, Mohd H, Michniak-Kohn B. Effect of penetration enhancers on transdermal delivery of oxcarbazepine, an antiepileptic drug using microemulsions. Pharmaceutics. 2023;15(1):183.
  22. Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, et al. Atorvastatin’s Reduction of Alzheimer’s Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2023;22(10):1462–71.
  23. Vashi AS. RENEWABLE RESOURCE-BASED POLYMERS AND PROPERTIES OF INTERPENETRATING POLYMER NETWORKS BASED ON CASTOR OIL.
  24. Singh D, Borra R, Patel SA. Non-oral cannabinoid formulation and method of treatment. Google Patents; 2020.
  25. Mohd H, Dopiera?a K, Zidar A, Virani A, Michniak-Kohn B. Effect of Edge Activator Combinations in Transethosomal Formulations for Skin Delivery of Thymoquinone via Langmuir Technique. Scientia Pharmaceutica. 2024;92(2):29.
  26. Brannon-Peppas L. Cosmetic and pharmaceutical applications of polymers. Journal of Controlled Release. 1993;23(2).
  27. Patel V, Bambharoliya T, Shah D, Patel D, Patel M, Shah U, et al. Eco-friendly Approaches to Chromene Derivatives: A Comprehensive Review of Green Synthesis Strategies. Current Topics in Medicinal Chemistry. 2024;
  28. A, H. S. Foams for pharmaceutical and cosmetic application. Vol. 394, International Journal of Pharmaceutics. 2010.
  29. vashi A. COMPREHENSIVE REVIEW ON THE CHARACTERISATION AND QUANTIFICATION OF PLGA IN PHARMACEUTICAL DRUG  PRODUCTS. WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2024;13(08):116–44.
  30. Borra R. Evaluate the Potency of Misoprostol for Management of Postpartum Hemorrhage in Maternal Women. International Journal Of Research In Pharmaceutical Sciences. 2020;11(3):1–5.
  31. López-Galindo A, Viseras C. Pharmaceutical and cosmetic applications of clays. In: Interface Science and Technology. 2004.
  32. Arzhavitina A, Steckel H. Foams for pharmaceutical and cosmetic application. Vol. 394, International Journal of Pharmaceutics. 2010.
  33. Virani A, Dholaria N, Mohd H, Albayati N, Michniak-Kohn B. Effect of chemical penetration enhancers on the transdermal delivery of olanzapine in human skin in vitro. AAPS Open. 2024;10(1):4.
  34. Cosmetic and Pharmaceutical Applications of Polymers. Cosmetic and Pharmaceutical Applications of Polymers. 1991.
  35. Patel BA, Sachdeva PD. EVALUATIONS OF ANTI-ASTHMATIC ACTIVITY OF ROOTS OF MORINGA OLEIFERA LAM. IN VARIOUS EXPERIMENTAL ANIMAL MODELS. Inventi Rapid: Planta Activa. 2011;
  36. Roy S, Majumder S, Deb A, Choudhury L. Microbial contamination of cosmetics and the pharmaceutical products, and their preservation strategies: A comprehensive review. Vol. 7, Novel Research in Microbiology Journal. 2023.
  37. Patel BA. NIOSOMES: A PROMISING APPROACH FOR ADVANCED DRUG DELIVERY IN CANCER TREATMENT. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(04):2747–52.
  38. Saharawat S, Verma S. A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications. Current Drug Delivery. 2024;21.
  39. Kuril AK, Vashi A. Identifying Trending Issues in Assay of Peptide Therapeutics During Stability Study. 2024;
  40. Kanlayavattanakul M, Lourith N. Lipopeptides in cosmetics. Vol. 32, International Journal of Cosmetic Science. 2010.
  41. Vashi A. Innovative approaches in characterizing and developing methods for lipoidal vesicular drug delivery systems. GSC Advanced Research and Reviews. 2024;20(1):427–38.
  42. Hemalatha S, Shaheedha SM, Borra R. Assessment of Prevalence of Hypertension in pregnant women with its Complications: A Cross Sectional Study. Research Journal of Pharmacy and Technology. 2021;14(7):3805–8.
  43. Brar KK, Raheja Y, Chadha BS, Magdouli S, Brar SK, Yang YH, et al. A paradigm shift towards production of sustainable bioenergy and advanced products from Cannabis/hemp biomass in Canada. Vol. 14, Biomass Conversion and Biorefinery. 2024.
  44. Kuril AK, Saravanan K. Particle Matter determination in Biosimilar Parenteral Product by the Application of Dynamic Light Scattering (DLS) Followed by Statistical Evaluation. European Journal of Parenteral and Pharmaceutical Sciences. 2024;29(2):1–13.
  45. Kuril AK, Saravanan K, Subbappa PK. Analytical Considerations for Characterization of Generic Peptide Product: A Regulatory Insight. Analytical Biochemistry. 2024;115633.
  46. Virani A. Advanced Drug Delivery With PLGA Copolymers. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(4):8116–24.
  47. Al-Fartoos MMR, Roy A, Mallick TK, Tahir AA. Advancing Thermoelectric Materials: A Comprehensive Review Exploring the Significance of One-Dimensional Nano Structuring. Vol. 13, Nanomaterials. 2023.
  48. PATEL BA, Patel MR. Novel solution formulation of cyclophosphamide. WO Patent WO2024112860A1; 2024.
  49. Patel BA. PERMEATION ENHANCEMENT AND ADVANCED STRATEGIES: A COMPREHENSIVE REVIEW OF IMPROVED TOPICAL DRUG DELIVERY. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(05):6691–702.
  50. Kumar K, Kumar R, Kaushal S, Thakur N, Umar A, Akbar S, et al. Biomass waste-derived carbon materials for sustainable remediation of polluted environment: A comprehensive review. Chemosphere. 2023;345.
  51. Vashi A. NANOPARTICLE BASED LIPOSOMES FOR DRUG DELIVERY: A REVIEW OF PHYSICOCHEMICAL CONSIDERATIONS.
  52. Vashi A, Kuril AK. CISPLATIN: A BEACON OF HOPE IN CANCER TREATMENT-UNVEILING THE POTENT ALKYLATING ANTINEOPLASTIC AGENT.
  53. Chettri A, Subba A, Singh GP, Bag PP. Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy. Vol. 76, Journal of Pharmacy and Pharmacology. 2024.
  54. Kuril AK. Differential Scanning Calorimetry: A Powerful and Versatile Tool for Analyzing Proteins and Peptides. Journal of Pharmaceutical Research International. 2024;36(7):179–87.
  55. Banik BK. Green Approaches in Medicinal Chemistry for Sustainable Drug Design. Green Approaches in Medicinal Chemistry for Sustainable Drug Design. 2020.
  56. Kuril AK, Saravanan K. High-throughput method for Peptide mapping and Amino acid sequencing for Calcitonin Salmon in Calcitonin Salmon injection using Ultra High Performance Liquid Chromatography–High Resolution Mass Spectrometry (UHPLC-HRMS) with the application of Bioinformatic tools. Journal of Pharmaceutical and Biomedical Analysis. 2024;243:116094.
  57. Puri V, Savla R, Chen K, Robinson K, Virani A, Michniak-Kohn B. Antifungal nail lacquer for enhanced transungual delivery of econazole nitrate. Pharmaceutics. 2022;14(10):2204.
  58. PATEL BA, Patel MR. Pharmaceutical Preparations Of Melatonin Suitable For Intranasal Administration. US Patent US20230143212A1; 2023.
  59. GÜR B, KARAGÖLGE Z. Sustainable Chemistry: Green Chemistry. Journal of the Institute of Science and Technology. 2016;6(2).
  60. Patel M, Thakkar A, Bhatt P, Shah U, Patel A, Solanki N, et al. Prominent targets for cancer care: immunotherapy perspective. Current Cancer Therapy Reviews. 2023;19(4):298–317.
  61. Darji DN, Kumar B, Bhandari A, Pasha TY. Green chemistry: Alternative synthetic strategy for drugs. International Journal of Pharmaceutical Research. 2010;2(4).
  62. Vashi A. CELL-BASED IN VITRO MODELS: EMERGING TECHNOLOGIES FOR ENHANCED DRUG PERMEABILITY PREDICTION.
  63. Sharma S, Gangal S, Rauf A. Green chemistry approach to the sustainable advancement to the synthesis of heterocyclic chemistry. Vol. 1, Rasayan Journal of Chemistry. 2008.
  64. Kuril AK, Saravanan K. Method Development and Validation for the Determination of Higher Molecular Weight Species of Calcitonin Salmon in Calcitonin Salmon Injection by High-Performance Size Exclusion Chromatography. International Journal of Pharmaceutical Sciences and Drug Research. 2024;1–7.                   
  65. Mathew D, Thomas B, Devaky KS. Green Catalysis, Green Chemistry, and Organic Syntheses for Sustainable Development. In: Chemistry and Chemical Engineering for Sustainable Development. 2020.
  66. Virani A, Dholaria N, Matharoo N, Michniak-Kohn B. A study of microemulsion systems for transdermal delivery of risperidone using penetration enhancers. Journal of Pharmaceutical Sciences. 2023;112(12):3109–19.
  67. Escribà Gelonch M. Green chemistry strategies for drug discovery. Green Processing and Synthesis. 2015;4(6).
  68. Patel BA, Patel MR. Solution formulation of cyclophosphamide. US Patent App. 18/517,285; 2024.
  69. Kameswara Srikar S, Dayal Giri D, Bahadur Pal D, Kumar Mishra P, Nath Upadhyay S. Green Synthesis of Silver Nanoparticles: A Review. Green and Sustainable Chemistry. Green and Sustainable Chemistry. 2016;6(February).
  70. Shah DD, Suthar RM, Solanki AB, Jadeja MB. EXPLORATION OF NOVEL CO-PROCESSED MULTIFUNCTIONAL EXCIPIENT FOR TABLET DOSAGE FORM. 2014;
  71. Srikar SK, Giri DD, Pal DB, Mishra PK, Upadhyay SN. Green Synthesis of Silver Nanoparticles: A Review. Green and Sustainable Chemistry. Green and Sustainable Chemistry. 2016;6(February).
  72. Badolato M, Aiello F, Neamati N. 2,3-Dihydroquinazolin-4(1: H)-one as a privileged scaffold in drug design. Vol. 8, RSC Advances. 2018.
  73. Yao Y, Zhang H, Hu K, Nie G, Yang Y, Wang Y, et al. Carbon dots based photocatalysis for environmental applications. Journal of Environmental Chemical Engineering. 2022;10(2).
  74. Dandia A, Saini P, Sethi M, Kumar K, Saini S, Meena S, et al. Nanocarbons in quantum regime: An emerging sustainable catalytic platform for organic synthesis. Catalysis Reviews - Science and Engineering. 2023;65(3).
  75. PATEL R, JADEJA M. DEVELOPMENT AND EVALUATION OF GEL CONTAINING PHOSPHATIDYLCHOLINE COMPLEXES OF ARBUTIN AND CURCUMIN AS SKIN WHITENING AGENT. International journal of biology, pharmacy and allied sciences. 2021;10(10):336–45.
  76. Kumari M, Pandey S, Giri VP, Nautiyal CS, Mishra A. A critical review on green approaches in shape and size evolution of metal nanoparticles and their environmental applications. Vol. 20, Environmental Nanotechnology, Monitoring and Management. 2023.
  77. Aoulad El Hadj Ali Y, Ahrouch M, Ait Lahcen A, Abdellaoui Y, Stitou M. Recent Advances and Prospects of Biochar-based Adsorbents for Malachite Green Removal: A Comprehensive Review. Vol. 6, Chemistry Africa. 2023.
  78. Singhal A, Baweja P, Gupta S, Chopra H, Gandhi PB. Biogenesis of nanoparticles using microorganisms: A Review. Vol. 10, Plant Science Today. 2023.
  79. Qin X, Ola O, Zhao J, Yang Z, Tiwari SK, Wang N, et al. Recent Progress in Graphene-Based Electrocatalysts for Hydrogen Evolution Reaction. Vol. 12, Nanomaterials. 2022.
  80. Suthar RM, Thumar RM, Jadeja MB, Lad BN. AN OVERVIEW ON SUSTAINED DRUG DELIVERY SYSTEM. Inventi Rapid: Pharm Tech. 2010;
  81. Krishnamoorthy S, Zait NN, Nasir AM, Ishar SM, Hamzah NH, Rus Din RD, et al. Towards development of green nanoparticles in applied health application: A mini review. Materials Today: Proceedings. 2023;
  82. Jadeja M, Patel R. DEVELOPMENT AND EVALUATION OF PHOSPHATIDYLCHOLINE COMPLEXES OF ARBUTIN AS SKIN WHITENING AGENT. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH. 2021;12(2):917–27.
  83. Leonel AG, Mansur AAP, Mansur HS. Advanced Functional Nanostructures based on Magnetic Iron Oxide Nanomaterials for Water Remediation: A Review. Vol. 190, Water Research. 2021.
  84. Suthar RM, Chotai NP, Patel HK, Patel SR, Shah DD, Jadeja MB. In vitro dissolution enhancement of ondansetron by solid dispersion in superdisintegrants. Dissol Technol. 2013;20(4):34–8.
  85. Mei J, Liao T, Sun Z. 2D/2D Heterostructures: Rational Design for Advanced Batteries and Electrocatalysis. Vol. 5, Energy and Environmental Materials. 2022.
  86. Dawit Negussie Tolossa, Gobezu Gotoro Gota. GREEN FINANCE’S IMPACT ON SUSTAINABLE DEVELOPMENT: INSIGHTS FROM DIVERSE PERSPECTIVES A SYSTEMATIC LITERATURE REVIEW. EPRA International Journal of Economics, Business and Management Studies. 2023;
  87. Joseph Sekhar S, Said Ahmed Al-Shahri A, Glivin G, Le THT, Mathimani T. A critical review of the state-of-the-art green ammonia production technologies- mechanism, advancement, challenges, and future potential. Fuel. 2024;358.
  88. Suthar RM, Chotai NP, Shah DD, Thumar RM, Patel HK, Jadeja MB. Development of Fast Dissolving Tablets Containing Ondansetron via Camphor Sublimation and its Characterization. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. 2012;1(1):1–6.
  89. Peng X, Zeng L, Wang D, Liu Z, Li Y, Li Z, et al. Electrochemical C-N coupling of CO2 and nitrogenous small molecules for the electrosynthesis of organonitrogen compounds. Vol. 52, Chemical Society Reviews. 2023.
  90. Saxena S, Johnson M, Dixit F, Zimmermann K, Chaudhuri S, Kaka F, et al. Thinking green with 2-D and 3-D MXenes: Environment friendly synthesis and industrial scale applications and global impact. Vol. 178, Renewable and Sustainable Energy Reviews. 2023.
  91. Zhang C, Wang H, Gao Y, Wan C. Cellulose-derived carbon aerogels: A novel porous platform for supercapacitor electrodes. Vol. 219, Materials and Design. 2022.
  92. Labanni A, Nasir M, Arief S. Research progress and prospect of copper oxide nanoparticles with controllable nanostructure, morphology, and function via green synthesis. Vol. 24, Materials Today Sustainability. 2023.
  93. Khan SJ, Badghish S, Kaur P, Sharma R, Dhir A. What motivates the purchasing of green apparel products? A systematic review and future research agenda. Business Strategy and the Environment. 2023;32(7).
  94. Santhosh CR, Sankannavar R. A comprehensive review on electrochemical green ammonia synthesis: From conventional to distinctive strategies for efficient nitrogen fixation. Applied Energy. 2023;352.

Reference

  1. Bailey CJ, Day C, Campbell IW, Schindler C. Glycaemic control and cardiovascular outcome trials in type 2 diabetes. Vol. 12, British Journal of Diabetes and Vascular Disease. 2012.
  2. Hinnen D, Kruger DF. Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials. Vol. 12, Diabetes, Metabolic Syndrome and Obesity. 2019.
  3. McEwan P, Chubb B, Bennett H. Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials. Value in Health. 2017;20(9).
  4. Cypryk K, Ma?ecki P. A review of cardiovascular outcome trials in type 2 diabetes. Endokrynologia Polska. 2018;69(4).
  5. Kapoor K, George P, Miller M. Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus. Vol. 135, Cardiology (Switzerland). 2016.
  6. Davies MJ, Drexel H, Jornayvaz FR, Pataky Z, Seferovi? PM, Wanner C. Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes. Vol. 21, Cardiovascular Diabetology. 2022.
  7. Bailey CJ, Marx N. Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials. Vol. 21, Diabetes, Obesity and Metabolism. 2019.
  8. Kruger DF. Cardiovascular outcome trials in type 2 diabetes: A nurse practitioner perspective. Journal of the American Association of Nurse Practitioners. 2018;30(1).
  9. Giugliano D, de Nicola L, Maiorino MI, Bellastella G, Esposito K. Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials. Vol. 21, Diabetes, Obesity and Metabolism. 2019.
  10. Schnell O, Rydén L, Standl E, Ceriello A. Current perspectives on cardiovascular outcome trials in diabetes. Vol. 15, Cardiovascular Diabetology. 2016.
  11. Coch RW, Green JB. Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight. Vol. 26, Nutrition, Metabolism and Cardiovascular Diseases. 2016.
  12. Gutiérrez RMP, Gómez JT, Urby RB, Soto JGC, Parra HR. Evaluation of Diabetes Effects of Selenium Nanoparticles Synthesized from a Mixture of Luteolin and Diosmin on Streptozotocin-Induced Type 2 Diabetes in Mice. Molecules. 2022;27(17).
  13. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. Journal of Nutrition. 2006;136(10).
  14. Patel P, Shah D, Bambharoliya T, Patel V, Patel M, Patel D, et al. A Review on the Development of Novel Heterocycles as ?-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus. Medicinal Chemistry. 2024;20(5):503–36.
  15. Kuril AK, Vashi A, Subbappa PK. A comprehensive guide for secondary structure and tertiary structure determination in peptides and proteins by circular dichroism spectrometer. Journal of Peptide Science. 2024;e3648.
  16. Wahab M, Janaswamy S. A review on biogenic silver nanoparticles as efficient and effective antidiabetic agents. Vol. 3, Functional Food Science. 2023.
  17. BORRA R. Formulation Development and Evaluation of Buccal Mucoadhesive Drug Delivery System for Anti Asthmatic Drugs.
  18. Ding M, Liu W, Gref R. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications. Vol. 190, Advanced Drug Delivery Reviews. 2022.
  19. Kuril AK. Navigating Mass Spectrometry: A Comprehensive Guide to Basic Concepts and Techniques.
  20. Abdelghany TM, Al-Rajhi AMH, al Abboud MA, Alawlaqi MM, Ganash Magdah A, Helmy EAM, et al. Recent Advances in Green Synthesis of Silver Nanoparticles and Their Applications: About Future Directions. A Review. Vol. 8, BioNanoScience. 2018.
  21. Virani A, Puri V, Mohd H, Michniak-Kohn B. Effect of penetration enhancers on transdermal delivery of oxcarbazepine, an antiepileptic drug using microemulsions. Pharmaceutics. 2023;15(1):183.
  22. Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, et al. Atorvastatin’s Reduction of Alzheimer’s Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2023;22(10):1462–71.
  23. Vashi AS. RENEWABLE RESOURCE-BASED POLYMERS AND PROPERTIES OF INTERPENETRATING POLYMER NETWORKS BASED ON CASTOR OIL.
  24. Singh D, Borra R, Patel SA. Non-oral cannabinoid formulation and method of treatment. Google Patents; 2020.
  25. Mohd H, Dopiera?a K, Zidar A, Virani A, Michniak-Kohn B. Effect of Edge Activator Combinations in Transethosomal Formulations for Skin Delivery of Thymoquinone via Langmuir Technique. Scientia Pharmaceutica. 2024;92(2):29.
  26. Brannon-Peppas L. Cosmetic and pharmaceutical applications of polymers. Journal of Controlled Release. 1993;23(2).
  27. Patel V, Bambharoliya T, Shah D, Patel D, Patel M, Shah U, et al. Eco-friendly Approaches to Chromene Derivatives: A Comprehensive Review of Green Synthesis Strategies. Current Topics in Medicinal Chemistry. 2024;
  28. A, H. S. Foams for pharmaceutical and cosmetic application. Vol. 394, International Journal of Pharmaceutics. 2010.
  29. vashi A. COMPREHENSIVE REVIEW ON THE CHARACTERISATION AND QUANTIFICATION OF PLGA IN PHARMACEUTICAL DRUG  PRODUCTS. WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2024;13(08):116–44.
  30. Borra R. Evaluate the Potency of Misoprostol for Management of Postpartum Hemorrhage in Maternal Women. International Journal Of Research In Pharmaceutical Sciences. 2020;11(3):1–5.
  31. López-Galindo A, Viseras C. Pharmaceutical and cosmetic applications of clays. In: Interface Science and Technology. 2004.
  32. Arzhavitina A, Steckel H. Foams for pharmaceutical and cosmetic application. Vol. 394, International Journal of Pharmaceutics. 2010.
  33. Virani A, Dholaria N, Mohd H, Albayati N, Michniak-Kohn B. Effect of chemical penetration enhancers on the transdermal delivery of olanzapine in human skin in vitro. AAPS Open. 2024;10(1):4.
  34. Cosmetic and Pharmaceutical Applications of Polymers. Cosmetic and Pharmaceutical Applications of Polymers. 1991.
  35. Patel BA, Sachdeva PD. EVALUATIONS OF ANTI-ASTHMATIC ACTIVITY OF ROOTS OF MORINGA OLEIFERA LAM. IN VARIOUS EXPERIMENTAL ANIMAL MODELS. Inventi Rapid: Planta Activa. 2011;
  36. Roy S, Majumder S, Deb A, Choudhury L. Microbial contamination of cosmetics and the pharmaceutical products, and their preservation strategies: A comprehensive review. Vol. 7, Novel Research in Microbiology Journal. 2023.
  37. Patel BA. NIOSOMES: A PROMISING APPROACH FOR ADVANCED DRUG DELIVERY IN CANCER TREATMENT. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(04):2747–52.
  38. Saharawat S, Verma S. A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications. Current Drug Delivery. 2024;21.
  39. Kuril AK, Vashi A. Identifying Trending Issues in Assay of Peptide Therapeutics During Stability Study. 2024;
  40. Kanlayavattanakul M, Lourith N. Lipopeptides in cosmetics. Vol. 32, International Journal of Cosmetic Science. 2010.
  41. Vashi A. Innovative approaches in characterizing and developing methods for lipoidal vesicular drug delivery systems. GSC Advanced Research and Reviews. 2024;20(1):427–38.
  42. Hemalatha S, Shaheedha SM, Borra R. Assessment of Prevalence of Hypertension in pregnant women with its Complications: A Cross Sectional Study. Research Journal of Pharmacy and Technology. 2021;14(7):3805–8.
  43. Brar KK, Raheja Y, Chadha BS, Magdouli S, Brar SK, Yang YH, et al. A paradigm shift towards production of sustainable bioenergy and advanced products from Cannabis/hemp biomass in Canada. Vol. 14, Biomass Conversion and Biorefinery. 2024.
  44. Kuril AK, Saravanan K. Particle Matter determination in Biosimilar Parenteral Product by the Application of Dynamic Light Scattering (DLS) Followed by Statistical Evaluation. European Journal of Parenteral and Pharmaceutical Sciences. 2024;29(2):1–13.
  45. Kuril AK, Saravanan K, Subbappa PK. Analytical Considerations for Characterization of Generic Peptide Product: A Regulatory Insight. Analytical Biochemistry. 2024;115633.
  46. Virani A. Advanced Drug Delivery With PLGA Copolymers. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(4):8116–24.
  47. Al-Fartoos MMR, Roy A, Mallick TK, Tahir AA. Advancing Thermoelectric Materials: A Comprehensive Review Exploring the Significance of One-Dimensional Nano Structuring. Vol. 13, Nanomaterials. 2023.
  48. PATEL BA, Patel MR. Novel solution formulation of cyclophosphamide. WO Patent WO2024112860A1; 2024.
  49. Patel BA. PERMEATION ENHANCEMENT AND ADVANCED STRATEGIES: A COMPREHENSIVE REVIEW OF IMPROVED TOPICAL DRUG DELIVERY. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(05):6691–702.
  50. Kumar K, Kumar R, Kaushal S, Thakur N, Umar A, Akbar S, et al. Biomass waste-derived carbon materials for sustainable remediation of polluted environment: A comprehensive review. Chemosphere. 2023;345.
  51. Vashi A. NANOPARTICLE BASED LIPOSOMES FOR DRUG DELIVERY: A REVIEW OF PHYSICOCHEMICAL CONSIDERATIONS.
  52. Vashi A, Kuril AK. CISPLATIN: A BEACON OF HOPE IN CANCER TREATMENT-UNVEILING THE POTENT ALKYLATING ANTINEOPLASTIC AGENT.
  53. Chettri A, Subba A, Singh GP, Bag PP. Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy. Vol. 76, Journal of Pharmacy and Pharmacology. 2024.
  54. Kuril AK. Differential Scanning Calorimetry: A Powerful and Versatile Tool for Analyzing Proteins and Peptides. Journal of Pharmaceutical Research International. 2024;36(7):179–87.
  55. Banik BK. Green Approaches in Medicinal Chemistry for Sustainable Drug Design. Green Approaches in Medicinal Chemistry for Sustainable Drug Design. 2020.
  56. Kuril AK, Saravanan K. High-throughput method for Peptide mapping and Amino acid sequencing for Calcitonin Salmon in Calcitonin Salmon injection using Ultra High Performance Liquid Chromatography–High Resolution Mass Spectrometry (UHPLC-HRMS) with the application of Bioinformatic tools. Journal of Pharmaceutical and Biomedical Analysis. 2024;243:116094.
  57. Puri V, Savla R, Chen K, Robinson K, Virani A, Michniak-Kohn B. Antifungal nail lacquer for enhanced transungual delivery of econazole nitrate. Pharmaceutics. 2022;14(10):2204.
  58. PATEL BA, Patel MR. Pharmaceutical Preparations Of Melatonin Suitable For Intranasal Administration. US Patent US20230143212A1; 2023.
  59. GÜR B, KARAGÖLGE Z. Sustainable Chemistry: Green Chemistry. Journal of the Institute of Science and Technology. 2016;6(2).
  60. Patel M, Thakkar A, Bhatt P, Shah U, Patel A, Solanki N, et al. Prominent targets for cancer care: immunotherapy perspective. Current Cancer Therapy Reviews. 2023;19(4):298–317.
  61. Darji DN, Kumar B, Bhandari A, Pasha TY. Green chemistry: Alternative synthetic strategy for drugs. International Journal of Pharmaceutical Research. 2010;2(4).
  62. Vashi A. CELL-BASED IN VITRO MODELS: EMERGING TECHNOLOGIES FOR ENHANCED DRUG PERMEABILITY PREDICTION.
  63. Sharma S, Gangal S, Rauf A. Green chemistry approach to the sustainable advancement to the synthesis of heterocyclic chemistry. Vol. 1, Rasayan Journal of Chemistry. 2008.
  64. Kuril AK, Saravanan K. Method Development and Validation for the Determination of Higher Molecular Weight Species of Calcitonin Salmon in Calcitonin Salmon Injection by High-Performance Size Exclusion Chromatography. International Journal of Pharmaceutical Sciences and Drug Research. 2024;1–7.                   
  65. Mathew D, Thomas B, Devaky KS. Green Catalysis, Green Chemistry, and Organic Syntheses for Sustainable Development. In: Chemistry and Chemical Engineering for Sustainable Development. 2020.
  66. Virani A, Dholaria N, Matharoo N, Michniak-Kohn B. A study of microemulsion systems for transdermal delivery of risperidone using penetration enhancers. Journal of Pharmaceutical Sciences. 2023;112(12):3109–19.
  67. Escribà Gelonch M. Green chemistry strategies for drug discovery. Green Processing and Synthesis. 2015;4(6).
  68. Patel BA, Patel MR. Solution formulation of cyclophosphamide. US Patent App. 18/517,285; 2024.
  69. Kameswara Srikar S, Dayal Giri D, Bahadur Pal D, Kumar Mishra P, Nath Upadhyay S. Green Synthesis of Silver Nanoparticles: A Review. Green and Sustainable Chemistry. Green and Sustainable Chemistry. 2016;6(February).
  70. Shah DD, Suthar RM, Solanki AB, Jadeja MB. EXPLORATION OF NOVEL CO-PROCESSED MULTIFUNCTIONAL EXCIPIENT FOR TABLET DOSAGE FORM. 2014;
  71. Srikar SK, Giri DD, Pal DB, Mishra PK, Upadhyay SN. Green Synthesis of Silver Nanoparticles: A Review. Green and Sustainable Chemistry. Green and Sustainable Chemistry. 2016;6(February).
  72. Badolato M, Aiello F, Neamati N. 2,3-Dihydroquinazolin-4(1: H)-one as a privileged scaffold in drug design. Vol. 8, RSC Advances. 2018.
  73. Yao Y, Zhang H, Hu K, Nie G, Yang Y, Wang Y, et al. Carbon dots based photocatalysis for environmental applications. Journal of Environmental Chemical Engineering. 2022;10(2).
  74. Dandia A, Saini P, Sethi M, Kumar K, Saini S, Meena S, et al. Nanocarbons in quantum regime: An emerging sustainable catalytic platform for organic synthesis. Catalysis Reviews - Science and Engineering. 2023;65(3).
  75. PATEL R, JADEJA M. DEVELOPMENT AND EVALUATION OF GEL CONTAINING PHOSPHATIDYLCHOLINE COMPLEXES OF ARBUTIN AND CURCUMIN AS SKIN WHITENING AGENT. International journal of biology, pharmacy and allied sciences. 2021;10(10):336–45.
  76. Kumari M, Pandey S, Giri VP, Nautiyal CS, Mishra A. A critical review on green approaches in shape and size evolution of metal nanoparticles and their environmental applications. Vol. 20, Environmental Nanotechnology, Monitoring and Management. 2023.
  77. Aoulad El Hadj Ali Y, Ahrouch M, Ait Lahcen A, Abdellaoui Y, Stitou M. Recent Advances and Prospects of Biochar-based Adsorbents for Malachite Green Removal: A Comprehensive Review. Vol. 6, Chemistry Africa. 2023.
  78. Singhal A, Baweja P, Gupta S, Chopra H, Gandhi PB. Biogenesis of nanoparticles using microorganisms: A Review. Vol. 10, Plant Science Today. 2023.
  79. Qin X, Ola O, Zhao J, Yang Z, Tiwari SK, Wang N, et al. Recent Progress in Graphene-Based Electrocatalysts for Hydrogen Evolution Reaction. Vol. 12, Nanomaterials. 2022.
  80. Suthar RM, Thumar RM, Jadeja MB, Lad BN. AN OVERVIEW ON SUSTAINED DRUG DELIVERY SYSTEM. Inventi Rapid: Pharm Tech. 2010;
  81. Krishnamoorthy S, Zait NN, Nasir AM, Ishar SM, Hamzah NH, Rus Din RD, et al. Towards development of green nanoparticles in applied health application: A mini review. Materials Today: Proceedings. 2023;
  82. Jadeja M, Patel R. DEVELOPMENT AND EVALUATION OF PHOSPHATIDYLCHOLINE COMPLEXES OF ARBUTIN AS SKIN WHITENING AGENT. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH. 2021;12(2):917–27.
  83. Leonel AG, Mansur AAP, Mansur HS. Advanced Functional Nanostructures based on Magnetic Iron Oxide Nanomaterials for Water Remediation: A Review. Vol. 190, Water Research. 2021.
  84. Suthar RM, Chotai NP, Patel HK, Patel SR, Shah DD, Jadeja MB. In vitro dissolution enhancement of ondansetron by solid dispersion in superdisintegrants. Dissol Technol. 2013;20(4):34–8.
  85. Mei J, Liao T, Sun Z. 2D/2D Heterostructures: Rational Design for Advanced Batteries and Electrocatalysis. Vol. 5, Energy and Environmental Materials. 2022.
  86. Dawit Negussie Tolossa, Gobezu Gotoro Gota. GREEN FINANCE’S IMPACT ON SUSTAINABLE DEVELOPMENT: INSIGHTS FROM DIVERSE PERSPECTIVES A SYSTEMATIC LITERATURE REVIEW. EPRA International Journal of Economics, Business and Management Studies. 2023;
  87. Joseph Sekhar S, Said Ahmed Al-Shahri A, Glivin G, Le THT, Mathimani T. A critical review of the state-of-the-art green ammonia production technologies- mechanism, advancement, challenges, and future potential. Fuel. 2024;358.
  88. Suthar RM, Chotai NP, Shah DD, Thumar RM, Patel HK, Jadeja MB. Development of Fast Dissolving Tablets Containing Ondansetron via Camphor Sublimation and its Characterization. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. 2012;1(1):1–6.
  89. Peng X, Zeng L, Wang D, Liu Z, Li Y, Li Z, et al. Electrochemical C-N coupling of CO2 and nitrogenous small molecules for the electrosynthesis of organonitrogen compounds. Vol. 52, Chemical Society Reviews. 2023.
  90. Saxena S, Johnson M, Dixit F, Zimmermann K, Chaudhuri S, Kaka F, et al. Thinking green with 2-D and 3-D MXenes: Environment friendly synthesis and industrial scale applications and global impact. Vol. 178, Renewable and Sustainable Energy Reviews. 2023.
  91. Zhang C, Wang H, Gao Y, Wan C. Cellulose-derived carbon aerogels: A novel porous platform for supercapacitor electrodes. Vol. 219, Materials and Design. 2022.
  92. Labanni A, Nasir M, Arief S. Research progress and prospect of copper oxide nanoparticles with controllable nanostructure, morphology, and function via green synthesis. Vol. 24, Materials Today Sustainability. 2023.
  93. Khan SJ, Badghish S, Kaur P, Sharma R, Dhir A. What motivates the purchasing of green apparel products? A systematic review and future research agenda. Business Strategy and the Environment. 2023;32(7).
  94. Santhosh CR, Sankannavar R. A comprehensive review on electrochemical green ammonia synthesis: From conventional to distinctive strategies for efficient nitrogen fixation. Applied Energy. 2023;352.

Photo
Avani Farasrami
Corresponding author

Student, Long Island University. 1 University plaza, Brooklyn, New York

Avani Farasrami , Recent Advances In Eco-Friendly Synthetic Approaches For Heterocyclic Compounds: Targeting Type-2 Diabetes And Beyond , Int. J. of Pharm. Sci., 2024, Vol 2, Issue 9, 109-120. https://doi.org/Avani Farasrami , Recent Advances In Eco-Friendly Synthetic Approaches For Heterocyclic Compounds: Targeting Type-2 Diabetes And Beyond , Int. J. of Pharm. Sci., 2024, Vol 2, Issue 9, 109-120. https://doi.org/10.5281/zenodo.13629409

More related articles
A Review Of Smart Nanoboat-Based Medication Delive...
Ashwini Wakade, Gaurav More, Megha Salve, ...
International Organization for Standardizations 90...
Madhushri Mane, Rajlaxmi Patil, Pritee Mudagal, Amruta Nikam, Nit...
A Review: Analytical Method Development and Valida...
Mukesh Patil, Ashish Jain, Roshani Dhumal, Shrusti Kadave, Aishw...
A Study on Efficacy of Erythropoietin Versus Erythropoietin with Desidustat in T...
Arifa Begum S. K., Asha Raj, Samreen, Swathi Boddupally , Are Bindhu, B. Bindu, Dileep Katikala, ...
A Safer Approach to Hair Care: Formulating Natural Anti-Dandruff Shampoo Alterna...
Manasvi Patil, Sakshi Patil, Priyanka Nalavade , Vaishnavi Jadhav, Akshata Nandarekar , Yogita Patil...
Related Articles
Formulation And Development Of Bilayer Tablets Of Cimetidine And Sucralfate For ...
Naumaan Naeem shaikh, Pradnya Palekar, Shanbhag Sanjana Jadhav, Samiksha Shinde, Akshaya Aravamudhan...
Concept And Recent Advancement In Tablet Coating Technologies: A Comprehensive R...
Shrikant S. Dongare, Mr. Dnyaneshwar S. Vyavhare, Dr. Megha T. Salve, ...
Exploring The Potentials Of Colebrookea Oppositifolia For Treatement Of Mouth Ul...
, Rahul Sharma, Chinu Kumari, Dev Prakash Dahiya, Nikhil Rana, Kanika, ...
More related articles
International Organization for Standardizations 9000 ...
Madhushri Mane, Rajlaxmi Patil, Pritee Mudagal, Amruta Nikam, Nita Sid, ...
A Review: Analytical Method Development and Validation ...
Mukesh Patil, Ashish Jain, Roshani Dhumal, Shrusti Kadave, Aishwarya Patil, ...
International Organization for Standardizations 9000 ...
Madhushri Mane, Rajlaxmi Patil, Pritee Mudagal, Amruta Nikam, Nita Sid, ...
A Review: Analytical Method Development and Validation ...
Mukesh Patil, Ashish Jain, Roshani Dhumal, Shrusti Kadave, Aishwarya Patil, ...